Genelux Corporation

NasdaqCM:GNLX Stock Report

Market Cap: US$98.1m

Genelux Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Tom Zindrick

Chief executive officer

US$1.5m

Total compensation

CEO salary percentage40.4%
CEO tenure11yrs
CEO ownership0.2%
Management average tenure1.8yrs
Board average tenure7.5yrs

Recent management updates

Recent updates

Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?

Feb 13
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?

Genelux: H2 2025 PRROC Data Is A Major Inflection Point

Oct 31

We're Keeping An Eye On Genelux's (NASDAQ:GNLX) Cash Burn Rate

Aug 24
We're Keeping An Eye On Genelux's (NASDAQ:GNLX) Cash Burn Rate

We're Hopeful That Genelux (NASDAQ:GNLX) Will Use Its Cash Wisely

Jan 29
We're Hopeful That Genelux (NASDAQ:GNLX) Will Use Its Cash Wisely

We're Not Very Worried About Genelux's (NASDAQ:GNLX) Cash Burn Rate

Sep 27
We're Not Very Worried About Genelux's (NASDAQ:GNLX) Cash Burn Rate

CEO Compensation Analysis

How has Tom Zindrick's remuneration changed compared to Genelux's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$1mUS$595k

-US$30m

Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$27m

Mar 31 2024n/an/a

-US$26m

Dec 31 2023US$6mUS$571k

-US$28m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$15m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$500kUS$500k

-US$5m

Sep 30 2022n/an/a

-US$5m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$17m

Dec 31 2021US$517kUS$500k

-US$16m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$2mUS$519k

-US$14m

Compensation vs Market: Tom's total compensation ($USD1.47M) is above average for companies of similar size in the US market ($USD662.66K).

Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.

CEO

Tom Zindrick (64 yo)

11yrs

Tenure

US$1,473,247

Compensation

Mr. Thomas Zindrick, also known as Tom, J.D., has been the Chief Executive Officer, Chief Compliance Officer and President at Genelux Corporation since May 2014. Mr. Zindrick has been Executive Chairman at...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Zindrick
Chairman11yrsUS$1.47m0.18%
$ 178.1k
Joseph Cappello
Chief Technical Officer1.8yrsUS$601.81k0.075%
$ 73.7k
Matthew Pulisic
CFO and Principal Financial & Accounting Officerless than a yearno datano data
Sean Ryder
General Counsel & Corporate Secretary3.6yrsUS$380.00k0.081%
$ 79.2k
Yong Yu
Senior Vice President of Clinical Development1.8yrsUS$242.62k0.065%
$ 63.7k
Paul Scigalla
Chief Medical Officer13.7yrsno data0%
$ 0
Ralph Smalling
VP & Head of Regulatory Affairs1.8yrsno data0.040%
$ 39.1k

1.8yrs

Average Tenure

64yo

Average Age

Experienced Management: GNLX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Thomas Zindrick
Chairman11yrsUS$1.47m0.18%
$ 178.1k
James Tyree
Lead Independent Director13yrsUS$284.13k0.017%
$ 16.4k
John Thomas
Non-Employee Independent Director22.7yrsUS$219.00k1.25%
$ 1.2m
Alan Forsythe
Member of Clinical Advisory Board2.3yrsno datano data
John Smither
Independent Director1.7yrsUS$231.50k0.022%
$ 21.5k
Mary Mirabelli
Non-Employee Independent Director3.9yrsUS$222.07k0.033%
$ 32.8k
Robert Coleman
Member of Clinical Advisory Boardno datano datano data
Thomas Herzog
Member of Clinical Advisory Boardno datano datano data
Alberto Mendivil
Member of Clinical Advisory Boardno datano datano data
Robert Holloway
Member of Clinical Advisory Boardno datano datano data
David O'Malley
Member of Clinical Advisory Boardno datano datano data

7.5yrs

Average Tenure

65.5yo

Average Age

Experienced Board: GNLX's board of directors are considered experienced (7.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 13:43
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genelux Corporation is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Brian Kemp DolliverBrookline Capital Markets
Michael SchmidtGuggenheim Securities, LLC